Invited contribution to the volume: "Stem cells & cancer stem cells, regenerative medicine & cancer" (VSI stem cells) reprogramming and transdifferentiation - two key processes for regenerative medicine.

Regenerative medicine based on transplants obtained from donors or foetal and new-born mesenchymal stem cells, encounter important obstacles such as limited availability of organs, ethical issues and immune rejection. The growing demand for therapeutic methods for patients being treated after serious accidents, severe organ dysfunction and an increasing number of cancer surgeries, exceeds the possibilities of the therapies that are currently available. Reprogramming and transdifferentiation provide powerful bioengineering tools. Both procedures are based on the somatic differentiated cells, which are easily and unlimitedly available, like for example.: fibroblasts. During the reprogramming procedure mature cells are converted into pluripotent cells - which are capable to differentiate into almost any kind of desired cells. Transdifferentiation directly converts differentiated cells of one type into another differentiated cells type. Both procedures allow to obtained patient's dedicated cells for therapeutic purpose in regenerative medicine. In combination with biomaterials, it is possible to obtain even whole anatomical structures. Those patient's dedicated structures may serve for them upon serious accidents with massive tissue damage but also upon cancer surgeries as a replacement of damaged organ. Detailed information about reprogramming and transdifferentiation procedures as well as the current state of the art are presented in our review.

[1]  E. Eftekharpour,et al.  Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells , 2017, Scientific Reports.

[2]  Marie-Pier Tétreault,et al.  Krüppel-like factors in cancer , 2013, Nature Reviews Cancer.

[3]  Wenbo Zhou,et al.  Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells , 2009, Stem cells.

[4]  J. Llovet,et al.  Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. , 2012, Gastroenterology.

[5]  Chul Soon Yong,et al.  Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Marek J. Łos,et al.  Heterogeneous Mixture of Amniotic Cells is Likely a Better Source of Stem Cells than Adipose Tissue , 2019, Archivum Immunologiae et Therapiae Experimentalis.

[7]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[8]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[9]  Marek J. Łos,et al.  Human induced pluripotent stem cell differentiation and direct transdifferentiation into corneal epithelial-like cells , 2016, Oncotarget.

[10]  U. Deuschle,et al.  Tetracycline-reversible silencing of eukaryotic promoters , 1995, Molecular and cellular biology.

[11]  Marek J. Łos,et al.  Composite Nanofibers Containing Multiwall Carbon Nanotubes as Biodegradable Membranes in Reconstructive Medicine , 2019, Nanomaterials.

[12]  S. Ku,et al.  Polypeptide Derivative of Metformin with the Combined Advantage of a Gene Carrier and Anticancer Activity. , 2019, ACS biomaterials science & engineering.

[13]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[14]  A. Nagy,et al.  Transgene-free production of pluripotent stem cells using piggyBac transposons. , 2011, Methods in molecular biology.

[15]  Daniel G Tenen,et al.  The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. , 2006, Genes & development.

[16]  M. Avci-Adali,et al.  Efficient reduction of synthetic mRNA induced immune activation by simultaneous delivery of B18R encoding mRNA , 2019, Journal of Biological Engineering.

[17]  A. Ramakrishnan,et al.  Efficient iPS cell generation from blood using episomes and HDAC inhibitors. , 2014, Journal of visualized experiments : JoVE.

[18]  T. McKay,et al.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming. , 2014, World journal of stem cells.

[19]  S. Navarro,et al.  High Oct4 expression: implications in the pathogenesis of neuroblastic tumours , 2019, BMC Cancer.

[20]  E. Poeschla,et al.  Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors , 1998, Nature Medicine.

[21]  R. Chandler,et al.  Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models. , 2017, Human gene therapy.

[22]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[23]  M. Tuszynski,et al.  Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? , 2004, Journal of neuroscience research.

[24]  D. Tosh,et al.  Transdifferentiation , 2019, eLS.

[25]  Marek J. Łos,et al.  Rational Design of a Conductive Collagen Heart Patch. , 2017, Macromolecular bioscience.

[26]  Kiyokazu Agata,et al.  Expression profiles during dedifferentiation in newt lens regeneration revealed by expressed sequence tags , 2010, Molecular vision.

[27]  J. Ellis,et al.  Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent states , 2008, Journal of cellular biochemistry.

[28]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[29]  Jin-Su Kim,et al.  Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers. , 2016, Macromolecular bioscience.

[30]  Hossein Baharvand,et al.  Concise Review: Alchemy of Biology: Generating Desired Cell Types from Abundant and Accessible Cells , 2011, Stem cells.

[31]  S. Stifani,et al.  Krüppel-like factor 7 is required for olfactory bulb dopaminergic neuron development. , 2011, Experimental cell research.

[32]  J. Pu,et al.  Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases , 2015, Neuroscience Bulletin.

[33]  L. Marchionni,et al.  In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins , 2011, Science Translational Medicine.

[34]  Daniel F Tardiff,et al.  Toward stem cell-based phenotypic screens for neurodegenerative diseases , 2015, Nature Reviews Neurology.

[35]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[36]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[37]  Stéphanie Boué,et al.  Methods for making induced pluripotent stem cells: reprogramming à la carte , 2011, Nature Reviews Genetics.

[38]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[39]  T. Hayakawa,et al.  Tumorigenicity-associated characteristics of human iPS cell lines , 2018, PloS one.

[40]  J. Rzeszowska-Wolny,et al.  The Impact of DIDS-Induced Inhibition of Voltage-Dependent Anion Channels (VDAC) on Cellular Response of Lymphoblastoid Cells to Ionizing Radiation. , 2017, Medicinal chemistry (Shariqah (United Arab Emirates)).

[41]  H. Nakauchi,et al.  Development of Defective and Persistent Sendai Virus Vector , 2010, The Journal of Biological Chemistry.

[42]  Li Qian,et al.  Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State , 2013, Stem cell reports.

[43]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[44]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[45]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[46]  A. Muotri,et al.  Efficient generation of human iPSCs by a synthetic self-replicative RNA. , 2013, Cell stem cell.

[47]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[48]  I. Greenwald,et al.  A Caenorhabditis elegans model for epithelial–neuronal transdifferentiation , 2008, Proceedings of the National Academy of Sciences.

[49]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[50]  Marius Wernig,et al.  A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types , 2008, Nature Biotechnology.

[51]  Sachin Kumar,et al.  An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. , 2019, Gene.

[52]  A. Brivanlou,et al.  A boost towards totipotency for stem cells , 2019, Nature Cell Biology.

[53]  P. Tsonis,et al.  Effects of a CDK inhibitor on lens regeneration , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[54]  K. Kataoka,et al.  MafA Is a Glucose-regulated and Pancreatic β-Cell-specific Transcriptional Activator for the Insulin Gene* , 2002, The Journal of Biological Chemistry.

[55]  Marzieh Ebrahimi,et al.  Neuropathological and genomic characterization of glioblastoma‐induced rat model: How similar is it to humans for targeted therapy? , 2019, Journal of cellular physiology.

[56]  T. Enver,et al.  Forcing cells to change lineages , 2009, Nature.

[57]  W. Likus,et al.  Correlations between selected parameters of nasal cavity in neonates and young infants - computed tomography study. , 2016, Folia morphologica.

[58]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[59]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[60]  T. Kondoh,et al.  Morphological differentiation of bone marrow stromal cells into neuron-like cells after co-culture with hippocampal slice , 2004, Brain Research.

[61]  H. Kimura,et al.  Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET , 2010, Nature.

[62]  K. Kawakami,et al.  Comparative analysis of transposable element vector systems in human cells. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[63]  E. Wiechec,et al.  Introduction to Transplantology , 2019, Stem Cells and Biomaterials for Regenerative Medicine.

[64]  Marek J. Łos,et al.  Cancer stem cells, cancer-initiating cells and methods for their detection. , 2016, Drug discovery today.

[65]  E. Newcomb,et al.  Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts , 1987, Cell.

[66]  Eun Young Kim,et al.  Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection , 2012, PloS one.

[67]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[68]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[69]  M. Serrano,et al.  Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.

[70]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[71]  I. Barshack,et al.  Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer‐binding protein β , 2007, Hepatology.

[72]  Shinsuke Yuasa,et al.  Induction of human cardiomyocyte-like cells from fibroblasts by defined factors , 2013, Proceedings of the National Academy of Sciences.

[73]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[74]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[75]  Xinjian Wang,et al.  Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs. , 2016, Cell stem cell.

[76]  G. Daley,et al.  Stem cells: Reprogramming in situ , 2013, Nature.

[77]  Zaiyi Liu,et al.  Tissue-Specific Progenitor and Stem Cells Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction , 2015 .

[78]  Sheng Ding,et al.  A chemical platform for improved induction of human iPSCs , 2009, Nature Methods.

[79]  H. Schöler,et al.  Generation of Human‐Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 , 2009, Stem cells.

[80]  J Kohyama,et al.  Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. , 2001, Differentiation; research in biological diversity.

[81]  S. Alavian,et al.  Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response. , 2015, World journal of gastroenterology.

[82]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[83]  Lin Liu,et al.  Generation of iPS Cells from Granulosa Cells. , 2014, Methods in molecular biology.

[84]  M. Gossen,et al.  Turning fibroblasts into cardiomyocytes: technological review of cardiac transdifferentiation strategies , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  J. Zimmer,et al.  Neural transdifferentiation of mesenchymal stem cells – a critical review , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[86]  P. Herrera,et al.  Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss , 2010, Nature.

[87]  H. Deng,et al.  Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.

[88]  K. Docherty,et al.  Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic β cell , 2008, Molecular and Cellular Endocrinology.

[89]  J Michael DiMaio,et al.  Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.

[90]  H. Schöler,et al.  Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming , 2016, Scientific Reports.

[91]  H. Clevers,et al.  Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer , 2019, Cell.

[92]  Deepak M. Gupta,et al.  A nonviral minicircle vector for deriving human iPS cells , 2010, Nature Methods.

[93]  Peter G Schultz,et al.  Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4 , 2009, Proceedings of the National Academy of Sciences.

[94]  P. Evans,et al.  Roles of Kruppel-like factor 4 in normal homeostasis, cancer and stem cells , 2008 .

[95]  S. Bonner-Weir,et al.  PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. , 2003, Diabetes.

[96]  B. Gumbiner,et al.  Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis , 2016, Mammalian Genome.

[97]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[98]  Anja M. Billing,et al.  Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers , 2016, Scientific Reports.

[99]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[100]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[101]  Daisuke Sugiyama,et al.  Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells , 2013, Stem Cell Research & Therapy.

[102]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[103]  D. Bachiller,et al.  Generation of Mouse and Human Induced Pluripotent Stem Cells (iPSC) from Primary Somatic Cells , 2013, Stem Cell Reviews and Reports.

[104]  KouichiC . Nakamura,et al.  Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters , 2007, Gene Therapy.

[105]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[106]  Jiuhong Kang,et al.  Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors , 2008, Cell Research.

[107]  Fred H. Gage,et al.  Development of a Self-Inactivating Lentivirus Vector , 1998, Journal of Virology.

[108]  B. Stanger,et al.  Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style , 2016, Nature Reviews Molecular Cell Biology.

[109]  S. Takagi,et al.  Evaluation of Transplanted Autologous Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in Exudative Age-Related Macular Degeneration. , 2019, Ophthalmology. Retina.

[110]  D. Schaffer,et al.  Biophysical regulation of epigenetic state and cell reprogramming. , 2013, Nature materials.

[111]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[112]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[113]  P. Pasceri,et al.  Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[114]  J Bondeson,et al.  Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  C. Lundberg,et al.  Lentiviral vectors for use in the central nervous system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[116]  J. Takahashi,et al.  Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors , 2012, Brain Research.

[117]  D. Melton,et al.  Extreme makeover: converting one cell into another. , 2008, Cell stem cell.

[118]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[119]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[120]  S. Yamanaka,et al.  Induction of pluripotent stem cells from fibroblast cultures , 2007, Nature Protocols.

[121]  J. C. Belmonte,et al.  Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration , 2011, Nature Reviews Molecular Cell Biology.

[122]  G. Michalopoulos,et al.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury , 2005, Hepatology.

[123]  Sean M. Wu,et al.  Reprogramming of Mouse, Rat, Pig, and Human Fibroblasts into iPS Cells , 2012, Current protocols in molecular biology.

[124]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[125]  J. Ito,et al.  Therapeutic potential of a gamma-secretase inhibitor for hearing restoration in a guinea pig model with noise-induced hearing loss , 2014, BMC Neuroscience.

[126]  D. Steinemann,et al.  Improved retroviral episome transfer of transcription factors enables sustained cell fate modification , 2014, Gene Therapy.

[127]  Jin Han,et al.  Three-dimensional culture may promote cell reprogramming , 2013, Organogenesis.

[128]  Yesong Wang,et al.  Adenovirus‐mediated expression of hypoxia‐inducible factor 1α double mutant converts neonatal cardiac fibroblasts into (cardio)myocyte phenotype , 2012, Cell biochemistry and function.

[129]  Emily Bernstein,et al.  Stem cells and reprogramming: breaking the epigenetic barrier? , 2011, Trends in pharmacological sciences.

[130]  Cizhong Jiang,et al.  Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails , 2015, Cell Research.

[131]  Jan Wolff,et al.  Application of Additive Manufacturing in Oral and Maxillofacial Surgery. , 2015, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[132]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[133]  Akshay S. Desai,et al.  Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial , 2016, The Lancet.

[134]  P. MacDonald,et al.  Stem cells to insulin secreting cells: two steps forward and now a time to pause? , 2014, Cell stem cell.

[135]  M. Yanik,et al.  Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins , 2010, PloS one.

[136]  A. Pawlik,et al.  Potential targets of gene therapy in the treatment of heart failure , 2018, Expert opinion on therapeutic targets.

[137]  S. Patra,et al.  Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression. , 2018, Gene.

[138]  Kevin Eggan,et al.  Conversion of mouse and human fibroblasts into functional spinal motor neurons. , 2011, Cell stem cell.

[139]  Marek J. Łos,et al.  Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis , 2018, Oncotarget.

[140]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[141]  P. Andrews,et al.  Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach , 2010, PloS one.

[142]  H. Deng,et al.  A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming , 2015, Cell.

[143]  Michael T Longaker,et al.  Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors , 2011, Nature Protocols.

[144]  D. Peeper,et al.  KLF4, p21 and context-dependent opposing forces in cancer , 2006, Nature Reviews Cancer.

[145]  M. Henriksson,et al.  Impact of MYC in regulation of tumor cell metabolism. , 2015, Biochimica et biophysica acta.

[146]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[147]  Liu Wang,et al.  Generation of dopaminergic neurons directly from mouse fibroblasts and fibroblast-derived neural progenitors , 2012, Cell Research.

[148]  M. Avci-Adali,et al.  Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA , 2019, Stem cells international.

[149]  E. Kuramoto,et al.  High-level transgene expression in neurons by lentivirus with Tet-Off system , 2009, Neuroscience Research.

[150]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[151]  Atique U. Ahmed,et al.  Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry , 2019, Stem cells international.

[152]  M. Pellegrini,et al.  Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming , 2018, BMC Genomics.

[153]  A. Kingsman,et al.  Stable gene transfer to the nervous system using a non-primate lentiviral vector , 1999, Gene Therapy.

[154]  Stem cells in regenerative medicine. , 2013 .

[155]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[156]  Changhong Li,et al.  Pdx1 maintains β cell identity and function by repressing an α cell program. , 2014, Cell metabolism.

[157]  A. Kuroiwa,et al.  Lens formation by pigmented epithelial cell reaggregate from dorsal iris implanted into limb blastema in the adult newt , 1999, Development, growth & differentiation.

[158]  Xin Li,et al.  A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.

[159]  Ye Seul Son,et al.  Efficient exogenous DNA-free reprogramming with suicide gene vectors , 2019, Experimental & Molecular Medicine.

[160]  P. Tsonis,et al.  Molecular and cellular aspects of amphibian lens regeneration , 2010, Progress in Retinal and Eye Research.

[161]  A. R. Thitoff,et al.  Unique expression patterns of the retinoblastoma (Rb) gene in intact and lens regeneration-undergoing newt eyes. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[162]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[163]  KaurKeerat,et al.  5-azacytidine promotes the transdifferentiation of cardiac cells to skeletal myocytes. , 2014 .

[164]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[165]  Yoshihide Hayashizaki,et al.  Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications , 2016, Stem Cell Reviews and Reports.

[166]  J. Staerk,et al.  Transdifferentiation—Changing Cell Identity , 2019, Stem Cells and Biomaterials for Regenerative Medicine.

[167]  H. Okano,et al.  Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.

[168]  I. Black,et al.  Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.

[169]  W. Birchmeier,et al.  E‐cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming , 2011, EMBO reports.

[170]  Thomas C. Südhof,et al.  Transdifferentiation of human adult peripheral blood T cells into neurons , 2018, Proceedings of the National Academy of Sciences.

[171]  Lei Zhang,et al.  In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. , 2014, Cell stem cell.

[172]  P. Trainor,et al.  Neural crest stem cells: discovery, properties and potential for therapy , 2012, Cell Research.

[173]  C. Schneider,et al.  OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness , 2017, Oncogene.

[174]  Y. Takeuchi,et al.  Porcine endogenous retrovirus and other viruses in xenotransplantation , 2009, Current opinion in organ transplantation.

[175]  Y. Atlasi,et al.  OCT‐4, an embryonic stem cell marker, is highly expressed in bladder cancer , 2007, International journal of cancer.

[176]  Ping Zhong,et al.  Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons , 2015, Nature Communications.

[177]  R. Reyer,et al.  Stimulation of lens regeneration from the newt dorsal iris when implanted into the blastema of the regenerating limb. , 1973, Developmental biology.

[178]  J. Slack.  Homoeotic transformations in man: implications for the mechanism of embryonic development and for the organization of epithelia. , 1985, Journal of theoretical biology.

[179]  N. Minami,et al.  Immobilized pH in culture reveals an optimal condition for somatic cell reprogramming and differentiation of pluripotent stem cells , 2016, Reproductive medicine and biology.

[180]  T. Tada,et al.  Mechanism of human somatic reprogramming to iPS cell , 2017, Laboratory Investigation.

[181]  Marius Wernig,et al.  The novel tool of cell reprogramming for applications in molecular medicine , 2017, Journal of Molecular Medicine.

[182]  M. Yano,et al.  The POU5F1 gene expression in colorectal cancer: a novel prognostic marker , 2018, Surgery Today.

[183]  H. Okano,et al.  The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa , 2014, Molecular Brain.

[184]  E. Papapetrou,et al.  Modeling blood diseases with human induced pluripotent stem cells , 2019, Disease Models & Mechanisms.

[185]  Marcella Birtele,et al.  Direct reprogramming into interneurons: potential for brain repair , 2019, Cellular and Molecular Life Sciences.

[186]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[187]  Weiqi Zhang,et al.  Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules , 2011, Cell Research.

[188]  A. SullengerBruce,et al.  RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit+ Cardiac Progenitor Cells , 2015 .

[189]  H. Schöler,et al.  Concise Review: Oct4 and More: The Reprogramming Expressway , 2012, Stem cells.

[190]  S. Dowdy,et al.  Protein transduction technology. , 2002, Current opinion in biotechnology.

[191]  T. Jay,et al.  Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming , 2018, Front. Mol. Neurosci..

[192]  H. Lehrach,et al.  The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. , 2012, Biomaterials.

[193]  V. Kumanan,et al.  Potential of ovine Wharton jelly derived mesenchymal stem cells to transdifferentiate into neuronal phenotype for application in neuroregenerative therapy , 2020, The International journal of neuroscience.

[194]  Maria Teresa Dell'Anno,et al.  Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming. , 2015, Cell stem cell.

[195]  G. Hatch,et al.  HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells , 2018, Molecular oncology.

[196]  Hamid Behrouj,et al.  Betulin and its derivatives as novel compounds with different pharmacological effects. , 2019, Biotechnology advances.

[197]  Ulrich Pfisterer,et al.  Direct conversion of human fibroblasts to dopaminergic neurons , 2011, Proceedings of the National Academy of Sciences.

[198]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[199]  P. Tsonis,et al.  Oocyte‐type linker histone B4 is required for transdifferentiation of somatic cells in vivo , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[200]  Yu Zhang,et al.  Conversion of human fibroblasts into functional cardiomyocytes by small molecules , 2016, Science.

[201]  Fajun Nan,et al.  Small molecule compound induces chromatin de-condensation and facilitates induced pluripotent stem cell generation. , 2014, Journal of molecular cell biology.

[202]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[203]  Boris Jerchow,et al.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates , 2009, Nature Genetics.

[204]  G. Wahl,et al.  Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.

[205]  T. Graf,et al.  Stepwise Reprogramming of B Cells into Macrophages , 2004, Cell.

[206]  C. Mummery,et al.  Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system. , 2013, Differentiation; research in biological diversity.

[207]  Marek J. Łos,et al.  LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis , 2018, Journal of cellular and molecular medicine.

[208]  P. Tsonis,et al.  A newt's eye view of lens regeneration. , 2004, The International journal of developmental biology.

[209]  Marek J. Łos,et al.  Amniotic cells share clusters of differentiation of fibroblasts and keratinocytes, influencing their ability to proliferate and aid in wound healing while impairing their angiogenesis capability. , 2019, European journal of pharmacology.

[210]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[211]  M. Kay,et al.  Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[212]  Hidenori Akutsu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[213]  I. Dixon,et al.  Reprogramming and carcinogenesis--parallels and distinctions. , 2014, International review of cell and molecular biology.

[214]  B. Malgrange,et al.  Concise Reviews: Regeneration in Mammalian Cochlea Hair Cells: Help from Supporting Cells Transdifferentiation. , 2017 .

[215]  Yoshihide Hayashizaki,et al.  A predictive computational framework for direct reprogramming between human cell types , 2016, Nature Genetics.

[216]  A. Seyfoori,et al.  Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response , 2017, Pharmacology & therapeutics.

[217]  Y. Assaraf,et al.  Could drugs inhibiting the mevalonate pathway also target cancer stem cells? , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[218]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[219]  M. Los,et al.  Novel trends in application of stem cells in skin wound healing , 2019, European journal of pharmacology.

[220]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[221]  M. Los,et al.  Direct Mechanical Stimulation of Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue Engineering , 2016, Advanced healthcare materials.

[222]  Natalia B. Ivanova,et al.  Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. , 2012, Cell stem cell.

[223]  C. Lengner,et al.  The pluripotency regulator Oct4: A role in somatic stem cells? , 2008, Cell cycle.

[224]  Sanjiv S. Gambhir,et al.  Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes , 2008, PloS one.

[225]  Marek J. Łos,et al.  New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets , 2017, Autophagy.

[226]  V. Patel,et al.  MiR‐590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte‐Like Fate by Directly Repressing Specificity Protein 1 , 2016, Journal of the American Heart Association.

[227]  L. Rojo,et al.  Biomaterials for Cleft Lip and Palate Regeneration , 2019, International journal of molecular sciences.

[228]  M. Nostro,et al.  Recent advances in cell replacement therapies for the treatment of type 1 diabetes. , 2015, Endocrinology.

[229]  H. Uusitalo,et al.  Human pluripotent stem cell-derived limbal epithelial stem cells on bioengineered matrices for corneal reconstruction. , 2016, Experimental eye research.

[230]  M. H. Jang,et al.  Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance , 2017, Oncotarget.

[231]  Frank Reimann,et al.  Diabetes Recovery By Age-Dependent Conversion of Pancreatic δ-Cells Into Insulin Producers , 2014, Nature.

[232]  Marzieh Ebrahimi,et al.  Glioblastoma cancer stem cell biology: Potential theranostic targets. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[233]  He Li,et al.  Multiple Directional Differentiation Difference of Neonatal Rat Fibroblasts from Six Organs , 2016, Cellular Physiology and Biochemistry.

[234]  S. Kochanek,et al.  Frequency and Stability of Chromosomal Integration of Adenovirus Vectors , 1999, Journal of Virology.

[235]  S. Ramaswamy,et al.  A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.

[236]  Lijian Shao,et al.  Gene-delivery systems for iPS cell generation , 2010, Expert opinion on biological therapy.

[237]  Gang Wang,et al.  Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy , 2011, Nature Cell Biology.

[238]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[239]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[240]  R. Shetty,et al.  Corneal cell therapy: with iPSCs, it is no more a far-sight , 2018, Stem Cell Research & Therapy.

[241]  S. Kelly.  Studies of the developmental potential of 4- and 8-cell stage mouse blastomeres. , 1977, The Journal of experimental zoology.

[242]  Naoki Nishishita,et al.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors , 2011, Proceedings of the National Academy of Sciences.

[243]  Wiem Chaabane,et al.  Human Gyrovirus-Apoptin Interferes with the Cell Cycle and Induces G2/M Arrest Prior to Apoptosis , 2017, Archivum Immunologiae et Therapiae Experimentalis.

[244]  Guoping Fan,et al.  Pancreatic β cell identity is maintained by DNA methylation-mediated repression of Arx. , 2011, Developmental cell.

[245]  S. Ghavami,et al.  Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies , 2019, Cancers.

[246]  K. Jin,et al.  Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression , 2003, Experimental Neurology.

[247]  M. Eghbali,et al.  Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[248]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[249]  R. Wells,et al.  Robust cellular reprogramming occurs spontaneously during liver regeneration. , 2013, Genes & development.

[250]  Z. Ivics,et al.  Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons. , 2014, Biochemical and biophysical research communications.

[251]  Marek J. Łos,et al.  Photodynamic N-TiO2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells , 2016, Scientific Reports.

[252]  Alexander Meissner,et al.  Molecular features of cellular reprogramming and development , 2016, Nature Reviews Molecular Cell Biology.

[253]  M. Grompe,et al.  Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. , 2014, Cell stem cell.

[254]  S. Dowdy,et al.  Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA , 2017, PloS one.

[255]  R. Gorchakov,et al.  Noncytopathic Replication of Venezuelan Equine Encephalitis Virus and Eastern Equine Encephalitis Virus Replicons in Mammalian Cells , 2005, Journal of Virology.